Novel Medical Treatment Modalities of Endometriosis
This review explores emerging medical treatments for endometriosis, a common condition affecting reproductive-aged women with infertility and pelvic pain for which no curative therapy currently exists.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (93)
- Angiogenic factors in endometriosis via openalex
- Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane via openalex
- Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model via openalex
- Anti-angiogenic treatment of endometriosis: biochemical aspects via openalex
- A pilot study on the off-label use of valproic acid to treat adenomyosis via openalex
- Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis via openalex
- Application of the nuclear factor-kappaB inhibitor BAY 11-7085 for the treatment of endometriosis: an in vitro study via openalex
- Atorvastatin causes regression of endometriotic implants in a rat model via openalex
- Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids via openalex
- Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions via openalex
- Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model via openalex
- Costunolide induces apoptosis in human endometriotic cells through inhibition of the prosurvival Akt and nuclear factor kappa B signaling pathway via openalex
- COX-2 inhibitors and their role in gynecology via openalex
- Curcumin as anti-endometriotic agent: implication of MMP-3 and intrinsic apoptotic pathway via openalex
- Detection of apoptosis in human endometriotic tissues via openalex
- Economic burden of endometriosis via openalex
- Effect of a Statin on an In Vitro Model of Endometriosis via openalex
- Effect of the immunomodulator leflunomide on the induction of endometriosis in an experimental rat model via openalex
- Effects of anti-TNF-mAb treatment on pregnancy in baboons with induced endometriosis via openalex
- Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia via openalex
- Effects of pinealectomy and melatonin supplementation on endometrial explants in a rat model via openalex
- Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons via openalex
- Efficacy of imiquimod, an immunomodulatory agent, on experimental endometriosis via openalex
- Efficacy of levamisole on experimental endometriosis via openalex
- Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis via openalex
- Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator via openalex
- Endostatin inhibits the growth of endometriotic lesions but does not affect fertility via openalex
- Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo via openalex
- Evidence for oxidatively modified lipid-protein complexes in endometrium and endometriosis via openalex
- Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours via openalex
- Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells via openalex
- Fenofibrate causes regression of endometriotic implants: a rat model via openalex
- FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine model via openalex
- Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? via openalex
- Interleukin-12 inhibits development of ectopic endometriotic tissues in peritoneal cavity via activation of NK cells in a murine endometriosis model via openalex
- In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells via openalex
- Matrix metalloproteinases and endometriosis via openalex
- Medical Therapy for Endometriosis via openalex
- Medical treatments for endometriosis via openalex
- Metformin as a new therapy for endometriosis, its effects on both clinical picture and cytokines profile via openalex
- Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9 via openalex
- More than antioxidant: N-acetyl-L-cysteine in a murine model of endometriosis via openalex
- Natural killer activity in stage III and IV endometriosis: impaired cytotoxicity and retained lymphokine responsiveness of natural killer cells via openalex
- Oxidative stress may be a piece in the endometriosis puzzle via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress via openalex
- Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial via openalex
- Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation via openalex
- Recombinant human TNF binding protein-1 (r-hTBP-1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. via openalex
- Regression of endometrial autografts in a rat model of endometriosis treated with etanercept via openalex
- Regression of endometrial explants in a rat model of endometriosis treated with melatonin via openalex
- Role of cytokines in the endometrial-peritoneal cross-talk and development of endometriosis via openalex
- Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis via openalex
- SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model via openalex
- Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells: a promising agent for the treatment of endometriosis via openalex
- Statins inhibit growth of human endometrial stromal cells independently of cholesterol availability via openalex
- Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice via openalex
- Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis via openalex
- Thiazolidinediones as therapy for endometriosis: a case series via openalex
- Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon via openalex
- Valproic acid and progestin inhibit lesion growth and reduce hyperalgesia in experimentally induced endometriosis in rats via openalex
- Vitamin E and C supplementation reduces endometriosis related pelvic pain via openalex
- W2182665322 via openalex
- W1970960196 via openalex
- W1910306760 via openalex
- W4376453583 via openalex
- W6641328778 via openalex
- W6644175530 via openalex
- W6645769035 via openalex
- W6658719099 via openalex
- W6660039260 via openalex
- W6665939090 via openalex
- W6675273733 via openalex
- W6850047429 via openalex
- W2160829078 via openalex
- W2082368668 via openalex
- W2070036336 via openalex
- W2066030592 via openalex
- W2053935373 via openalex
- W2046640023 via openalex
- W2045793734 via openalex
- W2126267641 via openalex
- W2032738969 via openalex
- W2132536626 via openalex
- W2132621306 via openalex
- W2001163191 via openalex
- W2137773942 via openalex
- W2140246703 via openalex
- W1992125460 via openalex
- W1975745957 via openalex
- W2144939915 via openalex
- W2078741915 via openalex
- W2164960015 via openalex
Cited by (3)
- Difficulties in Differentiation of Malignant Neoplasms and Deep Infiltrative Endometriosis 2022
- A combined approach to treating patients with severe forms of endometriosis-associated infertility 2017
- Combined treatment of endometriosis in infertile patients with gonadotropin-releasing hormone agonist or dienogest 2016
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00